Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

King Ups Medicaid Rebate Underpayment Estimate To $65 Mil.; CEO To Depart

Executive Summary

King Pharmaceuticals is raising its estimated Medicaid rebate underpayments by $18.9 mil. to $65.4 mil. following the completion of an internal audit, CFO Jim Lattanzi said during a Feb. 19 conference call

You may also be interested in...



King Says It Can Grow On Its Own Following Collapse Of Mylan Merger Plans

King will not pursue a new merger partner following the collapse of its proposed agreement to be acquired by Mylan

King Says It Can Grow On Its Own Following Collapse Of Mylan Merger Plans

King will not pursue a new merger partner following the collapse of its proposed agreement to be acquired by Mylan

Bristol And SEC Define “Normal” Inventory Levels As One Month

Bristol-Myers Squibb and the Securities & Exchange Commission have agreed to define "normal" wholesale inventory levels as approximately one-month worth of product on hand

Related Content

UsernamePublicRestriction

Register

PS043398

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel